WHO antimalarial trial guidelines: good science, bad news?

Ian Hastings; Ingrid Felger

doi:10.1016/j.pt.2022.08.005

WHO antimalarial trial guidelines: good science, bad news?

Ian Hastings
, Ingrid Felger

Tropical Disease Biology

Swiss TPH

Research output: Contribution to journal › Comment/debate

14 Citations (Scopus)

Original language	English
Pages (from-to)	933-941
Number of pages	9
Journal	Trends In Parasitology
Volume	38
Issue number	11
DOIs	https://doi.org/10.1016/j.pt.2022.08.005
Publication status	Published - 3 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

clinical trials
drug resistance
genotyping
malaria
molecular correction
therapeutic efficacy trials

Access to Document

10.1016/j.pt.2022.08.005

Cite this

@article{0c52531839214118b39329688fb50235,

title = "WHO antimalarial trial guidelines: good science, bad news?",

keywords = "clinical trials, drug resistance, genotyping, malaria, molecular correction, therapeutic efficacy trials",

author = "Ian Hastings and Ingrid Felger",

year = "2022",

month = sep,

day = "3",

doi = "10.1016/j.pt.2022.08.005",

language = "English",

volume = "38",

pages = "933--941",

journal = "Trends In Parasitology",

issn = "1471-4922",